Matthew Hershenhorn

Stock Analyst at Oppenheimer

(3.16)

# 2,528

Out of 5,088 analysts

Total ratings

50%

Success rate

49.4%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Hershenhorn

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AXSM Axsome Therapeutics	Reiterated: Buy	$280	$142.23	+96.87%	8	Oct 29, 2026
	ACAD Acadia Pharmaceuticals	Reiterated: Hold	$23 → $25	$20.58	+21.48%	7	Aug 5, 2026

Axsome Therapeutics

Oct 29, 2026

Reiterated: Buy

Price Target: $280

Current: $142.23

Upside: +96.87%

Acadia Pharmaceuticals

Aug 5, 2026

Reiterated: Hold

Price Target: $23 → $25

Current: $20.58

Upside: +21.48%